Allianz Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $422K | Sell |
|
|||||
|
2024
Q4 | $921K | Sell |
|
|||||
|
2024
Q3 | $997K | Buy |
|
|||||
|
2024
Q2 | $985K | Buy |
|
|||||
|
2024
Q1 | $1.11M | Buy |
|
|||||
|
2023
Q4 | $893K | Sell |
|
|||||
|
2023
Q3 | $1.12M | Buy |
|
|||||
|
2023
Q2 | $1.01M | Sell |
|
|||||
|
2023
Q1 | $3.92M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $8.62M | Sell |
|
|||||
|
2021
Q3 | $22.5M | Buy |
|
|||||
|
2021
Q2 | $12M | Buy |
|
|||||
|
2021
Q1 | $9.38M | Buy |
|
|||||
|
2020
Q4 | $3.31M | Sell |
|
|||||
|
2020
Q3 | $6.31M | Sell |
|
|||||
|
2020
Q2 | $5.36M | Sell |
|
|||||
|
2020
Q1 | $5.87M | Sell |
|
|||||
|
2019
Q4 | $11M | Sell |
|
|||||
|
2019
Q3 | $24.1M | Sell |
|
|||||
|
2019
Q2 | $34.2M | Buy |
|
|||||
|
2019
Q1 | $34.1M | Buy |
|
|||||
|
2018
Q4 | $20M | Sell |
|
|||||
|
2018
Q3 | $27.2M | Sell |
|
|||||
|
2018
Q2 | $24.1M | Sell |
|
|||||
|
2018
Q1 | $25.6M | Buy |
|
|||||
|
2017
Q4 | $23.4M | Buy |
|
|||||
|
2017
Q3 | $20.3M | Sell |
|
|||||
|
2017
Q2 | $27.1M | Sell |
|
|||||
|
2017
Q1 | $25.5M | Sell |
|
|||||
|
2016
Q4 | $23.7M | Buy |
|
|||||
|
2016
Q3 | $5.65M | Buy |
|
|||||
|
2016
Q2 | $2.4M | Buy |
|
|||||
|
2016
Q1 | $2.17M | Buy |
|
|||||
|
2015
Q4 | $1.91M | Buy |
|
|||||
|
2015
Q3 | $893K | Sell |
|
|||||
|
2015
Q2 | $2.05M | Sell |
|
|||||
|
2015
Q1 | $3.46M | Buy |
|
|||||
|
2014
Q4 | $992K | Sell |
|
|||||
|
2014
Q3 | $973K | Sell |
|
|||||
|
2014
Q2 | $916K | Sell |
|
|||||
|
2014
Q1 | $2.97M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $226K | Buy |
|